FARRAH ROSENTREADER: Open Payments
NPI 1467124412 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 9 payments from 6 companies in 2025. Trend: 2023 $322 · 2024 $489 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 3 | $53 |
| Vifor Pharma, Inc. | 2 | $36 |
| Janssen Biotech, Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $17 |
| ARGENX US, INC. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $9 |
Products named: VELPHORO, Veltassa, TREMFYA, DUPIXENT.
Industry payments across NE — which companies pay providers there.
